P2B-009

CTRC Institute for Drug Development, University of Texas (San Antonio, TX) › P2B-009

P2B-009

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
CTRC Institute for Drug Development, University of Texas (San Antonio, TX) · Dr. Muller
consented 2012-06-09

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 weight decreased with onset in cycle 4 (2012-08-30); assessed as not related to study drug (not related); resolved 2012-10-29.

mild assessed

Grade 1 vomiting with onset in cycle 1 (2012-06-29); assessed as related to study drug (possible); resolved 2012-06-30.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.